Is survival improved by the use of NIV and PEG in ALS?

“Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis? A post-mortem study of 80 ALS patients” has been published in the journal PLOS ONE. This work was supported in part by JPND through the SOPHIA project, selected in the 2011 Biomarkers call and the STRENGTH project, selected in the 2012 Risk Factors call.